Maria do Carmo F R Pinto Selected Research

nor-beta-lapachone

8/2008	Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi.
11/2007	Synthesis and potent antitumor activity of new arylamino derivatives of nor-beta-lapachone and nor-alpha-lapachone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria do Carmo F R Pinto Research Topics

Disease

4	Chagas Disease (American Trypanosomiasis) 08/2012 - 05/2008
1	Tuberculosis (Tuberculoses) 01/2016
1	Infections 02/2011
1	Neoplasms (Cancer) 11/2007
1	Melanoma (Melanoma, Malignant) 11/2007

Drug/Important Bio-Agent (IBA)

3	beta-lapachoneIBA 01/2016 - 11/2007
2	TriazolesIBA 02/2011 - 08/2008
2	NaphthoquinonesIBA 05/2010 - 05/2008
2	nor-beta-lapachoneIBA 08/2008 - 11/2007
1	phenazine FDA Link 01/2016
1	lapazineIBA 01/2016
1	benzonidazole (benznidazole)IBA 08/2012
1	Ethylene Oxide (Oxirane)IBA 08/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2011
1	AnthraquinonesIBA 05/2010
1	imidazoleIBA 05/2010
1	QuinonesIBA 11/2007
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2007

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 05/2008